Abbott Laboratories (ABT) Balance Sheet: Assets & Liabilities

Abbott Laboratories (ABT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Abbott Laboratories reported total assets of $86.71B and total liabilities of $33.94B. Shareholders' equity was $52.13B, up 9.4% from $47.66B a year earlier. Total debt stood at $12.93B against $8.94B in cash and short-term investments, a net debt position of $3.99B. That puts debt-to-equity at 0.25, compared with 0.30 a year earlier.

Abbott Laboratories Balance Sheet Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Abbott Laboratories (ABT) - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	8.52	7.62	6.90	9.88	9.80	6.84	3.86	3.84	9.41
Short-Term Investments	0.42	0.35	0.38	0.29	0.45	0.31	0.28	0.24	0.20
Cash & Short-Term Investments	8.94	7.97	7.28	10.17	10.25	7.15	4.14	4.09	9.61
Accounts Receivable	7.93	6.93	6.57	6.22	6.49	6.41	5.43	5.18	5.25
Inventory	6.49	6.19	6.57	6.17	5.16	5.01	4.32	3.80	3.60
Other Current Assets	2.64	2.57	2.26	2.66	2.35	1.87	1.79	1.57	1.69
Total Current Assets	26.00	23.66	22.67	25.22	24.24	20.44	15.67	14.63	20.15
Non-Current Assets
Property, Plant & Equipment (Net)	11.82	10.66	10.15	10.28	8.96	10.13	8.97	7.56	7.61
Long-Term Investments	0.92	0.89	0.80	0.77	0.90	1.03	0.93	0.90	0.88
Goodwill	24.04	23.11	23.68	22.80	23.23	23.74	23.20	23.25	24.02
Intangible Assets	5.53	6.65	8.82	10.45	12.74	14.78	17.03	18.94	21.47
Other Non-Current Assets	18.42	16.46	7.10	4.92	5.21	2.42	2.10	1.89	2.12
Total Non-Current Assets	60.72	57.76	50.54	49.21	50.96	52.11	52.22	52.54	56.10
Total Assets	86.71	81.41	73.21	74.44	75.20	72.55	67.89	67.17	76.25
Current Liabilities
Accounts Payable	4.24	4.20	4.30	4.61	4.41	3.95	3.25	2.98	2.40
Short-Term Debt	3.03	1.50	1.08	2.48	0.75	0.46	1.68	0.21	0.71
Current Portion of Long-Term Debt	3.03	1.50	1.08	2.25	0.75	-	-	-	-
Accrued Liabilities	6.88	6.22	7.02	6.76	6.44	-	-	-	-
Other Current Liabilities	1.67	7.61	1.45	8.06	7.39	7.14	5.70	5.53	5.49
Total Current Liabilities	16.50	14.16	13.84	15.49	13.11	11.91	10.86	9.01	8.91
Non-Current Liabilities
Long-Term Debt	9.90	12.63	13.60	15.47	17.30	19.43	17.42	19.36	27.21
Deferred Tax Liabilities	0.56	0.51	0.57	1.84	1.39	2.15	2.13	2.06	2.01
Other Non-Current Liabilities	2.54	2.59	6.95	4.74	3.69	6.06	6.18	6.02	7.02
Total Non-Current Liabilities	17.45	19.36	20.55	22.04	26.07	27.64	25.72	27.44	36.24
Total Liabilities	33.94	33.51	34.39	37.53	39.17	39.55	36.59	36.45	45.15
Stockholders' Equity
Common Stock	25.53	25.15	24.87	24.71	24.47	24.15	23.85	23.51	23.21
Retained Earnings	49.78	47.26	37.55	35.26	31.53	27.63	25.85	24.56	23.98
Accumulated Other Comprehensive Income	-6.00	-7.91	-7.84	-8.05	-8.37	-8.95	-8.47	-7.59	-6.06
Treasury Stock	17.18	16.84	15.98	15.23	11.82	-	-	-	-
Additional Paid-in Capital	0.00	-16.84	-15.98	-15.23	-11.82	-10.04	-10.15	-9.96	-10.23
Minority Interest	0.64	0.24	0.22	0.22	0.22	0.22	0.21	0.20	0.20
Shares Outstanding	1.74	1.73	1.73	1.74	1.76	-	-	-	-
Total Stockholders' Equity	52.13	47.66	38.83	36.69	35.80	32.78	31.09	30.52	30.90
Total Liabilities & Equity	86.71	81.41	73.21	74.44	75.20	72.55	67.89	67.17	76.25

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Abbott Laboratories Balance Sheet

How much debt does Abbott Laboratories have?

Abbott Laboratories had total debt of $12.93B as of Dec 31, 2025, against $8.94B in cash and short-term investments. Its debt-to-equity ratio was 0.25. Total debt was $14.13B a year earlier.

What are Abbott Laboratories's total assets?

Abbott Laboratories reported total assets of $86.71B as of Dec 31, 2025, up 6.5% from $81.41B a year earlier. Total liabilities were $33.94B.

What is Abbott Laboratories's shareholders' equity?

Abbott Laboratories's shareholders' equity was $52.13B as of Dec 31, 2025, or about $30.02 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition